LCM
TNDM icon

Legato Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Legato Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,085
Closed -$960K – 841
2026
Q1 		$960K Sell
50,085
-22,495
-31% -$489K 0.09% 305
2025
Q4 		$1.6M Buy
+72,580
New +$1.31M 0.14% 230
2025
Q3 		– Sell
-48,185
Closed -$898K – 625
2025
Q2 		$898K Buy
+48,185
New +$954K 0.11% 307
2025
Q1 		– Sell
-20,335
Closed -$732K – 619
2024
Q4 		$732K Buy
20,335
+6,530
+47% +$221K 0.1% 373
2024
Q3 		$585K Sell
13,805
-15,065
-52% -$639K 0.07% 422
2024
Q2 		$1.16M Buy
28,870
+10,845
+60% +$452K 0.16% 218
2024
Q1 		$638K Buy
18,025
+7,215
+67% +$193K 0.08% 383
2023
Q4 		$320K Buy
+10,810
New +$224K 0.04% 485
2023
Q3 		– Sell
-14,676
Closed -$360K – 646
2023
Q2 		$360K Buy
14,676
+3,849
+36% +$124K 0.05% 473
2023
Q1 		$440K Sell
10,827
-4,785
-31% -$198K 0.08% 378
2022
Q4 		$702K Buy
+15,612
New +$707K 0.13% 260

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Legato Capital Management's TNDM Position: Q2 2026 in Review

Legato Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 50,085 shares — an estimated $960K sold.

Legato Capital Management first reported a position in TNDM in Q4 2022 and held it in 11 quarters. The position peaked at $1.6M in Q4 2025. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Legato Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Legato Capital Management sold 50,085 Tandem Diabetes Care shares in Q2 2026, an estimated $960K.
  • Legato Capital Management first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 11 quarters.
  • Legato Capital Management's Tandem Diabetes Care position peaked at $1.6M in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.